Thanks for a successful 4th East-West Biopharma SummitJoin us for the 5th Summit in Seoul, March 2026
Delegates: Access the Conference Platform

This Year’s Theme: How to Globalize Asia Innovation 

From China and Japan, to South Korea and Singapore, Asia biotechs must globalize to succeed. Many are licensing global rights to Western biopharmas. Others are pursuing the "Newco Model," partnering with Western investors to launch new biotechs in the U.S. or Europe.

At the 4th East-West Summit, you will meet key players looking to globalize innovation from across Asia.

See for yourself: Join us for two days of C-level networking, partnering and debate, tailored for VCs, CEOs, CFOs, CBOs and decision-makers driving biopharma innovation in Asia and the West.

Download the conference brochureLearn more about the Summit, who you will meet, the schedule-at-a-glance and more.

MEET THE SPEAKERS

Sharon Chan, DPhil
VP, Asia Pacific
JLABS, Johnson & Johnson
Sridhar Gopal
Head, International Business Development
AbbVie
Mia Hu
Investment Director
Boehringer Ingelheim Venture Fund
Amit Kakar
Head of Asia
Novo Holdings
Jami Rubin
Senior Managing Director
Guggenheim Securities
Qiusong Tang, Ph.D.
Head
Roche Accelerator China
Moreright-arrow

What Will I Learn?

Highlights:

Globalizing Asian Innovation: The BioCentury Scene Setter asks whether routing Asia assets to the West can be sustained, and will it result in more Asia biotechs?

The NewCo Model: The Investor Roundtable asks whether Western and Asia investors see NewCos as the best path forward to globalizing Asia's innovation?

Pharma Licensing: The Dealmakers Showcase asks pharma BD&L leaders if the wave of licensing from Asia is here to stay.

AND MUCH MORE: VIEW THE AGENDA >>

Explore the AgendaDebate strategies to globalize Asia's Emerging Arc of Innovation, from Dealmaking to the NewCo Model.

Let BioCentury help you find your next partner with the Presenting Companies Dashboard.

More than 25 biotechs have been selected to present by BioCentury. Visit the Presenting Company Dashboard to learn more about each company, including unpartnered assets you may want to target.

View the Dashboard >>

Apply to Present >>

Why Should I Attend?

The East-West Summit is a premier C-level conference for Asian and Western biopharma executives and investors: Expand your network, debate strategy, find the right partner.

Network, partner and debate with:

  • VCs and PEs
  • Biopharma BD&L Leaders
  • Biotech C-Suite
  • Family Offices
  • Financial Dealmakers

Meet key players from across Asia-Pacific, including:

  • Australia
  • China
  • Japan
  • India
  • South Korea
  • Singapore and Southeast Asia

Discover your next partner at the East-West Biopharma Summit.Advanced rates end Feb. 24, 2025.

Organizing Committee

Fidah Alsagoff, M.D.
Vice Chairman, Healthcare & Life Sciences (Global Partnerships)
Temasek International
Fong Ming Koh, Ph.D.
Investment Principal
LYFE Capital
James Huang
Managing Partner
Panacea Venture
Amy Schulman
Managing Partner
Polaris Partners
Khoo Shih, Ph.D.
CEO
ClavystBio
Carl Firth, Ph.D.
Partner
Panacea Venture
Moreright-arrow
Explore Asia’s emerging Arc of Innovation in Singapore.

Ribbon

Ribbon (copy)